Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.33 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | HTT | P42858 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19639574 | 0.90 | SMN1; SMN2 (0.33) | SMN1; SMN2GAATSHRPDCD1CD274 | |
| SCHEMBL19639578 | 0.87 | HCAR2 (0.35) | SMN1; SMN2GAATSHRPDCD1CD274 | |
| SCHEMBL19639548 | 0.87 | HCAR2 (0.35) | SMN1; SMN2GAATSHRPDCD1CD274 | |
| SCHEMBL19639531 | 0.87 | ALDH1A1 (0.42) | SMN1; SMN2TSHRPDCD1CD274ALDH1A1 | |
| SCHEMBL19639554 | 0.87 | CHRNB2 (0.32) | SMN1; SMN2GAATSHRPDCD1CD274 | |
| SCHEMBL19639565 | 0.87 | CHRNB2 (0.32) | SMN1; SMN2GAATSHRPDCD1CD274 | |
| SCHEMBL19639560 | 0.80 | ESR1 (0.35) | SMN1; SMN2GAAALDH1A1LMNATP53 | |
| SCHEMBL19639525 | 0.80 | KDM4E (0.35) | SMN1; SMN2GAAALDH1A1HTTLMNA | |
| SCHEMBL19639551 | 0.78 | MAPT (0.39) | SMN1; SMN2TSHRALDH1A1HTTLMNA | |
| SCHEMBL1592742 | 0.77 | NPSR1 (0.33) | TSHRALDH1A1HTTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170342026-A1 | ISOPROPOXY-PHENYLGUANIDINE SERIES SALT AND APPLICATION THEREOF IN PREPARING GROWTH PROMOTERS FOR ANIMAL FEED | Guangzhou Insighter Biotechnology Co., Ltd. (CN) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170342026-A1 | ISOPROPOXY-PHENYLGUANIDINE SERIES SALT AND APPLICATION THEREOF IN PREPARING GROWTH PROMOTERS FOR ANIMAL FEED | SUCNR1, SORD, BPGM | SMN1; SMN2 2247/4885GAA 754/4885TSHR 1815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.